Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
12/2012
12/04/2012US8323967 Enhancing stem cell mobilization
12/04/2012US8323964 proteolytic fragment of a growth differentiation factor (GDF) polypeptide (pro-GDF) or a functional peptide portion thereof; affects activity associated with GDF signal transduction
12/04/2012US8323962 Molecules with extended half-lives, compositions and uses thereof
12/04/2012US8323959 Microorganisms for therapy
12/04/2012US8323950 Methods and organisms for utilizing synthesis gas or other gaseous carbon sources and methanol
12/04/2012US8323946 Alpha-amylase mutants
12/04/2012US8323945 Variant alpha-amylases from Bacillus subtilis and methods of uses, thereof
12/04/2012US8323933 Vector for transformation using transposons, microorganisms transformed by the vector, and method for producing L-lysine using the same
12/04/2012US8323932 Expression of granular starch hydrolyzing enzymes in Trichoderma and process for producing glucose from granular starch substrates
12/04/2012US8323929 Methods for detecting nucleic acid sequence variations
12/04/2012US8323926 Gene from Hancenula polymorpha capable of controlling unfolded protein response and method for increasing effect of secretion using the same
12/04/2012US8323917 Method of screening for compounds that inhibit the enzymatic activity of GWT1 gene product
12/04/2012US8323902 Methods for producing soluble membrane-spanning proteins
12/04/2012US8323897 Multiplex amplification of polynucleotides
12/04/2012US8323896 Epidermal growth factor (EGF) expression and/or polymorphisms thereof for predicting the risk of developing cancer
12/04/2012US8323894 Methods of analysis of allelic imbalance
12/04/2012US8323893 Administration of exogenous miRNA or siRNA
12/04/2012US8323892 Hybridization method and apparatus
12/04/2012US8323891 miRNA triplex formations for the downregulation of viral replication
12/04/2012US8323890 Process for high-throughput DNA methylation analysis
12/04/2012US8323888 Nanoparticles having oligonucleotides attached thereto and uses therefor
12/04/2012US8323887 Miniaturized fluid delivery and analysis system
12/04/2012US8323884 Isolated SNARE YKT6 genomic polynucleotide fragments from chromosome 7 and their uses
12/04/2012US8323664 Live vaccine strains of Francisella
12/04/2012US8323651 Antibodies to receptor of advanced glycation end products (RAGE) and uses thereof
12/04/2012US8323646 Engineered anti-IL-13 antibodies, compositions, methods and uses
12/04/2012US8323640 Highly functional enzyme having α-galactosidase activity
12/04/2012CA2524387C Modified yeast cells expressing exogenous xylose isomerase
11/2012
11/29/2012WO2012162161A1 Microsporidia detection system and method
11/29/2012WO2012161806A1 Modulation of stat3 expression
11/29/2012WO2012109476A9 Methods and compositions related to staufen 1 binding sites formed by duplexing alu elements
11/29/2012WO2012106670A8 Expandable liquid volume in an led bulb
11/29/2012WO2012102877A3 Centromere sequences derived from sugar cane and minichromosomes comprising the same
11/29/2012WO2008045970A8 Compositions and methods of using chondroitinase abci mutants
11/29/2012WO2006091470A8 Improved halohydrin dehalogenases and related polynucleotides
11/29/2012US20120304330 Elite event ee-gm3 and methods and kits for identifying such event in biological samples
11/29/2012US20120304317 Transgenic rodent expressing truncated disc1
11/29/2012US20120302741 Non-invasive detection of fetal genetic traits
11/29/2012US20120302732 Chimeric immunoreceptor useful in treating human cancers
11/29/2012US20120302628 Oligonucleotides which inhibit p53 induction in response to cellular stress
11/29/2012US20120302623 Novel Activation and Transfer Cascade for Ubiquitin
11/29/2012US20120302622 Conjugates, particles, compositions, and related methods
11/29/2012US20120302457 Population Scale HLA-Typing and Uses Therof
11/29/2012US20120301943 Dry Reagent, Dry Reagent Kit, Reagent Container, and Method for Producing Dry Reagent
11/29/2012US20120301926 Methods for manipulating biomolecules
11/29/2012US20120301880 Alkyl amine compounds for fluorescent labeling
11/29/2012US20120301879 Novel use of ca-125
11/29/2012US20120301874 Compositions and Methods for Detection of Staphylococcus Aureus
11/29/2012US20120301503 Influenza hemagglutinin and neuraminidase variants
11/29/2012US20120301494 Proteolysis-resistant capsid of chimeric hepatitis e virus as an oral delivery vector
11/29/2012US20120301457 LIPID COFACTORS FOR FACILITATING PROPOGATION OF PRPsc
11/29/2012DE602004036672C5 Nukleinsäureamplifikation auf Basis von Kügelchenemulsion Nucleic acid amplification-based emulsion globules
11/28/2012EP2527501A1 Polymorphisms predictive of anthracycline-induced cardiotoxicity
11/28/2012EP2527460A1 Methods for prediction of clinical outcome to epidermal growth factor receptor inhibitors by cancer patients
11/28/2012EP2527444A2 Antisense oligonucleotide modulation of stat3 expression
11/28/2012EP2527354A1 Compositions and methods for inhibiting expression of Eg5 gene
11/28/2012EP2526970A1 Monitoring cancer stem cells
11/28/2012EP2526969A1 Monitoring cancer stem cells
11/28/2012EP2526113A1 Post-synthetic chemical modification of rna at the 2'-position of the ribose ring via "click" chemistry
11/28/2012EP2526112A1 Targeted genomic alteration
11/28/2012CN1738829B New 2',5'-oligoadenylic acid analog
11/28/2012CN102803284A Chemical modification motifs for miRNA inhibitors and mimetics
11/28/2012CN102803283A Expression Cassettes Derived From Maize
11/28/2012CN102796732A Method for producing ribonucleic acid of yeast
11/28/2012CN102796717A Thermostable amylase polypeptides, nucleic acids encoding those polypeptides and uses thereof
11/28/2012CN101711281B Use of CTHRC1 in diagnosing cancer of liver
11/28/2012CN101296702B Compositions and methods for the diagnosis and therapy of BCL2-associated cancers
11/28/2012CN101194018B Site-specific serine recombinases and methods of their use
11/27/2012US8319062 Plants and seeds of hybrid corn variety CH650068
11/27/2012US8318926 Anti-MicroRNA oligonucleotide molecules
11/27/2012US8318925 RNAi therapeutic for treatment of hepatitis C infection
11/27/2012US8318924 Immunostimulatory siRNA molecules
11/27/2012US8318923 Nucleic acid modulators of glycoprotein VI
11/27/2012US8318922 Treatment and prevention of hyperproliferative conditions in humans and antisense oligonucleotide inhibition of human replication-initiation proteins
11/27/2012US8318921 A new approach to sequence-specific silencing of a silencing target, triggered RNAi, has been developed based on the triggered hybridization of nucleic acid molecules, typically starting from monomer hairpins; detection target may be an mRNA associated with a cancer
11/27/2012US8318920 Therapeutic nucleic acid-3′-conjugates
11/27/2012US8318919 Nucleic acid hybridization methods
11/27/2012US8318917 Nucleic acids encoding antibodies having altered effector function and methods for making the same
11/27/2012US8318916 Human CTLA-4 antibodies and their uses
11/27/2012US8318915 Kit for detection of bacterial species by means of DNA analysis
11/27/2012US8318914 Elongases and methods for producing polyunsaturated fatty acids in transgenic organisms
11/27/2012US8318912 Targeted immune conjugate comprising an antibody to glycophorin A and a M2e peptide
11/27/2012US8318911 Anti-EpCAM antibody and uses thereof
11/27/2012US8318909 Antibodies for diagnosis and treatment of blood platelet alloimmune disorders
11/27/2012US8318693 Compositions and methods for inhibiting expression of mutant EGFR gene
11/27/2012US8318692 Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy
11/27/2012US8318689 SiRNA-based cancer treatment
11/27/2012US8318688 Compositions and methods for altering RNAi
11/27/2012US8318687 Recombinant adeno-associated virus vector for treatment of Alzheimer disease
11/27/2012US8318686 Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein
11/27/2012US8318496 Compounds and methods for improving cellular uptake of oligomeric compounds
11/27/2012US8318471 Nitrilases, nucleic acids encoding them and methods for making and using them
11/27/2012US8318463 Δ8 desaturases and their use in making polyunsaturated fatty acids
11/27/2012US8318460 Haplotype analysis
11/27/2012US8318458 Polypeptides having beta-glucosidase activity and polynucleotides encoding same
11/27/2012US8318456 Two helix binders
11/27/2012US8318437 USP47 inhibitors and methods to induce apoptosis
11/27/2012US8318436 Use of genetically modified organisms to generate biomass degrading enzymes
11/27/2012US8318435 DNA extraction method for bursaphelenchus xylophilus from wood chips, lamp primer set for bursaphelenchus xylophilus, and detection method for bursaphelenchus xylophilus from wood chips
11/27/2012US8318432 Cross-reactive hybridization probe for detecting HIV-1 and HIV-2 nucleic acids in the P31 gene sequence
1 ... 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 ... 899